Jones T - Search Results

1

The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing.

Ranicar AS, Williams CW, Schnorr L, Clark JC, Rhodes CG, Bloomfield PM, Jones T. Ranicar AS, et al. Among authors: jones t. Med Prog Technol. 1991;17(3-4):259-64. Med Prog Technol. 1991. PMID: 1839859

2

Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.

Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH. Rechavia E, et al. Among authors: jones t. J Am Coll Cardiol. 1997 Aug;30(2):533-8. doi: 10.1016/s0735-1097(97)00180-0. J Am Coll Cardiol. 1997. PMID: 9247529

3

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Saleem A, Harte RJ, Matthews JC, Osman S, Brady F, Luthra SK, Brown GD, Bleehen N, Connors T, Jones T, Price PM, Aboagye EO. Saleem A, et al. Among authors: jones t. J Clin Oncol. 2001 Mar 1;19(5):1421-9. doi: 10.1200/JCO.2001.19.5.1421. J Clin Oncol. 2001. PMID: 11230487 Clinical Trial.

4

Effect of nifedipine on myocardial metabolism in patients with unstable angina.

Araujo LI, Camici P, Spinks TJ, Jones T, Maseri A. Araujo LI, et al. Among authors: jones t. Eur Heart J. 1987 Nov;8 Suppl K:9-13. doi: 10.1093/eurheartj/8.suppl_k.9. Eur Heart J. 1987. PMID: 3450526

5

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, Jones T, Marsden CD, Frackowiak RS. Leenders KL, et al. Among authors: jones t. Arch Neurol. 1990 Dec;47(12):1290-8. doi: 10.1001/archneur.1990.00530120034007. Arch Neurol. 1990. PMID: 2123623

6

The role of positron emission tomography within the spectrum of medical imaging.

Jones T. Jones T. Eur J Nucl Med. 1996 Feb;23(2):207-11. doi: 10.1007/BF01731847. Eur J Nucl Med. 1996. PMID: 8925858 Review.

7

Glucose metabolism in brain tumours can be estimated using [18F]2-fluorodeoxyglucose positron emission tomography and a population-derived input function scaled using a single arterialised venous blood sample.

Brock CS, Young H, Osman S, Luthra SK, Jones T, Price PM. Brock CS, et al. Among authors: jones t. Int J Oncol. 2005 May;26(5):1377-83. doi: 10.3892/ijo.26.5.1377. Int J Oncol. 2005. PMID: 15809731 Clinical Trial.

8

Positron emission tomography (PET) methodology for small animals and its application in radiopharmaceutical preclinical investigation.

Hume SP, Jones T. Hume SP, et al. Among authors: jones t. Nucl Med Biol. 1998 Nov;25(8):729-32. doi: 10.1016/s0969-8051(98)00055-9. Nucl Med Biol. 1998. PMID: 9863557 Review.

9

Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals.

Hume SP, Gunn RN, Jones T. Hume SP, et al. Among authors: jones t. Eur J Nucl Med. 1998 Feb;25(2):173-6. doi: 10.1007/s002590050211. Eur J Nucl Med. 1998. PMID: 9473266

10

Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography.

Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, Hughes JM. Brudin LH, et al. Among authors: jones t. Eur J Nucl Med. 1994 Apr;21(4):297-305. doi: 10.1007/BF00947964. Eur J Nucl Med. 1994. PMID: 8005153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results